ISSN: 2155-9872

Journal of Analytical & Bioanalytical Techniques
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Steven C Moore

Chair of the Consortium of Metabolomics Studies

Biography

Dr. Steven Moore earned his Ph.D. in Cancer Epidemiology from Yale University School of Public Health. He joined the Nutritional Epidemiology Branch of the NCI Division of Cancer Epidemiology and Genetics as a Pre-doctoral Fellow in 2005 and became a Research Fellow in 2009. Dr. Moore was appointed as an Earl Stadtman Tenure-Track Investigator in 2013. Dr. Moore’s research focuses on the role of physical activity and obesity in the development of cancer. He has received a number of awards for his work in this area, including a DCEG Fellowship Achievement Award, as well as the Karen Hornbostel Memorial Award from the American College of Sports Medicine.

Research Interest

Dr. Moore’s research focuses on the role of obesity-related factors on cancer risk, including waist circumference, sedentary behavior, and physical activity. He is exploring these questions in large population-based studies, such as the NIH-AARP Diet and Health Study cohort, and within the NCI Cohort Consortium, a group which has pooled data from nearly two million individuals. Dr. Moore seeks to establish the reduction in cancer rates that would occur if all people were more physically active, including for rare cancers and specific cancer subtypes.  Dr. Moore is a pioneer in the field of metabolomics, which applies novel high-throughput technology to analyze small-molecule metabolites in biospecimens, like blood or urine, as a way to understand how molecular pathways may influence cancer risk. In studying the metabolomics of energy balance, he has been instrumental in uncovering biomarkers for body mass index and diet. Dr. Moore is leading studies to identify metabolites and metabolic pathways involved in breast cancer and is a lead collaborator on studies of colorectal and pancreatic cancer.

Global Speakers in the subject

Global Experts in the subject

Top